Impact of abuse on migraine symptoms and comorbidity

Emotional, physical, and sexual abuse are associated with an increased risk for developing migraine. Such abuse is linked to more severe migraine-related sensory hypersensitivity symptoms according to the results of a new study presented at AAN 2021 by Dr Meesha Trivedi, Mayo Clinic, AZ.

Risk of developing migraine following abuse

60% of adults with migraine experience of abuse

In 2016, a retrospective cross-sectional analysis of the Ad Health Dataset revealed that 60% of adults self-reporting migraine also reported experience of abuse. For 58% of these adults, this was emotional abuse,1 said Dr Trivedi, who highlighted that the risk of developing migraine among people who experience abuse is increased by:

·         comorbid depression and anxiety1,2

·         type of abuse1,3

·         increased number of types of abuse3

·         higher frequency of abuse4

 

Impact of abuse on patients with migraine

Abuse was associated with significantly greater headache frequency

Dr Trivedi described a study she carried out with colleagues of adult patients with migraine to investigate the impact of abuse on migraine-related sensory hypersensitivity and the role of comorbid depression and anxiety.

Patients were asked to complete questionnaires to evaluate anxiety, depression, photosensitivity, hyperacusis, and allodynia, and to provide a self-reported abuse history.

Of the 1020 patients recruited from the American Registry for Migraine Research who completed the questionnaires (38% response rate), 36% reported a history of abuse (n=365).

Abuse was associated with significantly greater anxiety and depression

Abuse was associated with significantly greater headache frequency (additional 1.5 headache days per month; p=0.019), anxiety (p<0.001), depression (p<0.001), photophobia (p<0.001), hyperacusis (p<0.001), ictal allodynia (p<0.001), and interictal allodynia (p=0.001).

After controlling for age, gender, and headache frequency, abuse was significantly associated with photophobia (p<0.001), hyperacusis (p<0.001), ictal allodynia (p<0.001) and interictal allodynia (p=0.002).

Abuse was significantly associated with photophobia, hyperacusis, and ictal and interictal allodynia

Both anxiety and depression significantly mediated the relationships between abuse and photophobia, hyperacusis, and ictal allodynia.

Dr Trivedi concluded that further research is needed to determine the pathophysiologic mechanisms underlying the relationship between abuse, psychiatric comorbidities, and migraine symptoms.

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Tietjen GE, et al. Emotional abuse history and migraine among young adults: a retrospective cross-sectional analysis of the Add Health Dataset. Headache 2017;57:45–59.
  2. Tietjen GE, et al. Recalled maltreatment, migraine, and tension-type headache. Neurology  2015;84:132–40.
  3. Brennenstuhl S, et al. The painful legacy of childhood violence: migraine headaches among adult survivors of adverse childhood experiences. Headache 2015;55:973–83.
  4. Fuh J-L, et al. Relationship between childhood physical maltreatment and migraine in adolescents. Headache 2010;50:761–8.
  5. Trivedi M, et al. Impact of abuse on migraine symptoms and comorbidity: results from the American Registry for Migraine Research (ARMR) (2187). Neurology 2021;96 (15 Supplement). Available at https://n.neurology.org/content/96/15_Supplement/2187. Accessed 13 Jun 21.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country